# OnCo record jain-hasmukh (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/jain-hasmukh/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "jain-hasmukh" ;
  schema:name "Hasmukh Jain"@en ;
  schema:description "First author of the phase 1/2 trial of India's first CAR-T therapy, which treated adults with relapsed lymphoma and leukaemia at six Indian centres."@en ;
  schema:url <https://onco.cc/people/jain-hasmukh/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://tmc.gov.in>, <https://pubmed.ncbi.nlm.nih.gov/?term=Jain%20H%5BAuthor%5D%20Tata%20Memorial%20lymphoma%20CAR> ;
  schema:jobTitle "Professor of Medical Oncology (adult haematolymphoid), Tata Memorial Hospital" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> ;
  onco:drugs <https://onco.cc/drugs/talicabtagene-autoleucel/> ;
  onco:institutions <https://onco.cc/institutions/tata-memorial/> ;
  onco:trials <https://onco.cc/trials/talicel-phase-1-2/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-jain-talicabtagene-lancet-haem-2025/> ;
  schema:affiliation <https://onco.cc/institutions/tata-memorial/> .